Drug repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information

Adikusuma, Wirawan and Irham, Lalu Muhammad and Chou, Wan-Hsuan and Wong, Henry Sung-Ching and Mugiyanto, Eko and Ting, Jafit and Perwitasari,, Dyah Aryani and Chang, Wei Pin- (2021) Drug repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information. Frontiers in Immunology, 12.

[thumbnail of HASIL CEK_60160916_Drug Repurposing (1).pdf] Text
HASIL CEK_60160916_Drug Repurposing (1).pdf

Download (2MB)


Atopic Dermatitis (AD) is a chronic and relapsing skin disease. The medications for treating AD are still limited, most of them are topical corticosteroid creams or antibiotics. The current study attempted to discover potential AD treatments by integrating a gene network and genomic analytic approaches. Herein, the Single Nucleotide Polymorphism (SNPs) associated with AD were extracted from the GWAS catalog. We identified 70 AD-associated loci, and then 94 AD risk genes were found by extending to proximal SNPs based on r2 > 0.8 in Asian populations using HaploReg v4.1. Next, we prioritized the AD risk genes using in silico pipelines of bioinformatic analysis based on six functional annotations to identify biological AD risk genes. Finally, we expanded them according to the molecular interactions using the STRING database to find the drug target genes. Our analysis showed 27 biological AD risk genes, and they were mapped to 76 drug target genes. According to DrugBank and Therapeutic Target Database, 25 drug target genes overlapping with 53 drugs were identified. Importantly, dupilumab, which is approved for AD, was successfully identified in this bioinformatic analysis. Furthermore, ten drugs were found to be potentially useful for AD with clinical or preclinical evidence. In particular, we identified filgotinub and fedratinib, targeting gene JAK1, as potential drugs for AD. Furthermore, four monoclonal antibody drugs (lebrikizumab, tralokinumab, tocilizumab, and canakinumab) were successfully identified as promising for AD repurposing. In sum, the results showed the feasibility of gene networking and genomic information as a potential drug discovery resource.

Item Type: Artikel Umum
Subjects: R Medicine > RS Pharmacy and materia medica
Divisi / Prodi: Faculty of Pharmacy (Fakultas Farmasi) > S2-Master of Pharmacy (S2-Farmasi)
Depositing User: Lalu Muhammad Irham, M.Farm., Ph.D
Date Deposited: 08 Jun 2022 05:15
Last Modified: 02 Nov 2022 06:24
URI: http://eprints.uad.ac.id/id/eprint/35185

Actions (login required)

View Item View Item